Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen J McManus

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The New Zealand Medical Journal|April 24, 2020
Perry syndrome: a case of atypical parkinsonism with confirmed DCTN1 mutationEileen J McManus, Gemma Poke, Matthew Cl Phillips, et al.
Neuro-Oncology Practice|January 31, 2022
Metabolics risk factors in a New Zealand glioblastoma cohortEileen J McManus, Chris Frampton, Alvin Tan, et al.
Frontiers in Behavioral Neuroscience|August 15, 2022
Time-Restricted Ketogenic Diet in Huntington's Disease: A Case StudyMatthew C L Phillips, Eileen J McManus, Martijn Brinkhuis, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 28, 2022
Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple SclerosisEileen J McManus, Karen M Clark, Christopher Frampton, et al.
Alzheimer'S Research & Therapy|February 24, 2021
Randomized crossover trial of a modified ketogenic diet in Alzheimer's diseaseMatthew C L Phillips, Laura M Deprez, Grace M N Mortimer, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The New Zealand Medical Journal|April 24, 2020
Perry syndrome: a case of atypical parkinsonism with confirmed DCTN1 mutationEileen J McManus, Gemma Poke, Matthew Cl Phillips, et al.
Neuro-Oncology Practice|January 31, 2022
Metabolics risk factors in a New Zealand glioblastoma cohortEileen J McManus, Chris Frampton, Alvin Tan, et al.
Frontiers in Behavioral Neuroscience|August 15, 2022
Time-Restricted Ketogenic Diet in Huntington's Disease: A Case StudyMatthew C L Phillips, Eileen J McManus, Martijn Brinkhuis, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 28, 2022
Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple SclerosisEileen J McManus, Karen M Clark, Christopher Frampton, et al.
Alzheimer'S Research & Therapy|February 24, 2021
Randomized crossover trial of a modified ketogenic diet in Alzheimer's diseaseMatthew C L Phillips, Laura M Deprez, Grace M N Mortimer, et al.
Pageof 1